- Pfizer said its Covid-19 pill, used with an HIV drug, cut the risk of hospitalization or death by 89% in high-risk adults who’ve been exposed to the virus.
- It’s now the second antiviral pill behind Merck’s to demonstrate strong effectiveness for treating Covid at the first sign of illness.
- Pfizer said it plans to submit its data to the Food and Drug Administration “as soon as possible.”
- https://www.cnbc.com/2021/11/05/pfizer-says-its-covid-pill-with-hiv-drug-cuts-the-risk-of-hospitalization-or-death-by-89percent.html
Submitted November 05, 2021 at 08:06AM by RagionamentiFinanza https://ift.tt/3bQ09kN
